With its own COVID-19 vaccine trial on pause, Sanofi will produce 12 million doses of Johnson & Johnson’s candidate

·1 min read

While its own COVID-19 vaccine candidate faces trial delays, French drug maker Sanofi will use its vaccine manufacturing plant in Marcy L'Etoike, France, to formulate and fill vials with Johnson & Johnson's single-dose shot. The goal, Sanofi said, is to produce about 12 million doses in its facility.

The companies are considered rivals, but Sanofi CEO Paul Hudson said the company is "stepping forward to show solidarity" amid the coronavirus pandemic, even as it remains focused on eventually moving forward with its own trials.

Sanofi previously agreed to help bottle and package 125 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech. Read more at The Associated Press.

More stories from theweek.com
Rochester police who killed Daniel Prude during mental health crisis won't face charges
Amy Klobuchar shuts down Ron Johnson's conspiracy mongering at Capitol attack hearing
Justin Trudeau tells Biden 'U.S. leadership has been sorely missed over the past years'

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting